Switch to:
Also traded in: Australia, Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 4/10

vs
industry
vs
history
Cash to Debt 0.96
HTWR's Cash to Debt is ranked lower than
62% of the 326 Companies
in the Global Medical Devices industry.

( Industry Median: 2.32 vs. HTWR: 0.96 )
Ranked among companies with meaningful Cash to Debt only.
HTWR' s Cash to Debt Range Over the Past 10 Years
Min: 0.96  Med: 2.17 Max: No Debt
Current: 0.96
Equity to Asset 0.39
HTWR's Equity to Asset is ranked lower than
79% of the 304 Companies
in the Global Medical Devices industry.

( Industry Median: 0.63 vs. HTWR: 0.39 )
Ranked among companies with meaningful Equity to Asset only.
HTWR' s Equity to Asset Range Over the Past 10 Years
Min: 0.33  Med: 0.55 Max: 0.96
Current: 0.39
0.33
0.96
F-Score: 2
Z-Score: 1.75
M-Score: -2.69
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 4/10

vs
industry
vs
history
Operating margin (%) -16.99
HTWR's Operating margin (%) is ranked lower than
65% of the 308 Companies
in the Global Medical Devices industry.

( Industry Median: 2.42 vs. HTWR: -16.99 )
Ranked among companies with meaningful Operating margin (%) only.
HTWR' s Operating margin (%) Range Over the Past 10 Years
Min: -8846.69  Med: -52.07 Max: -0.04
Current: -16.99
-8846.69
-0.04
Net-margin (%) -23.03
HTWR's Net-margin (%) is ranked lower than
67% of the 308 Companies
in the Global Medical Devices industry.

( Industry Median: 1.87 vs. HTWR: -23.03 )
Ranked among companies with meaningful Net-margin (%) only.
HTWR' s Net-margin (%) Range Over the Past 10 Years
Min: -7157.83  Med: -59.91 Max: -6.96
Current: -23.03
-7157.83
-6.96
ROE (%) -31.98
HTWR's ROE (%) is ranked lower than
70% of the 303 Companies
in the Global Medical Devices industry.

( Industry Median: 1.47 vs. HTWR: -31.98 )
Ranked among companies with meaningful ROE (%) only.
HTWR' s ROE (%) Range Over the Past 10 Years
Min: -99.79  Med: -43.63 Max: -9.51
Current: -31.98
-99.79
-9.51
ROA (%) -12.88
HTWR's ROA (%) is ranked lower than
62% of the 330 Companies
in the Global Medical Devices industry.

( Industry Median: 0.20 vs. HTWR: -12.88 )
Ranked among companies with meaningful ROA (%) only.
HTWR' s ROA (%) Range Over the Past 10 Years
Min: -86.09  Med: -30.14 Max: -4.54
Current: -12.88
-86.09
-4.54
ROC (Joel Greenblatt) (%) -92.66
HTWR's ROC (Joel Greenblatt) (%) is ranked lower than
68% of the 325 Companies
in the Global Medical Devices industry.

( Industry Median: 3.44 vs. HTWR: -92.66 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
HTWR' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: -770.36  Med: -127.08 Max: -10.07
Current: -92.66
-770.36
-10.07
Revenue Growth (3Y)(%) 27.20
HTWR's Revenue Growth (3Y)(%) is ranked higher than
94% of the 233 Companies
in the Global Medical Devices industry.

( Industry Median: 3.90 vs. HTWR: 27.20 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
HTWR' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: 0  Med: 40.3 Max: 420.7
Current: 27.2
0
420.7
EBITDA Growth (3Y)(%) -17.40
HTWR's EBITDA Growth (3Y)(%) is ranked lower than
82% of the 195 Companies
in the Global Medical Devices industry.

( Industry Median: 4.00 vs. HTWR: -17.40 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
HTWR' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -17.4  Med: -7.75 Max: 35.4
Current: -17.4
-17.4
35.4
EPS Growth (3Y)(%) -11.90
HTWR's EPS Growth (3Y)(%) is ranked lower than
72% of the 196 Companies
in the Global Medical Devices industry.

( Industry Median: 2.70 vs. HTWR: -11.90 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
HTWR' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -33.9  Med: -11.9 Max: 42
Current: -11.9
-33.9
42
» HTWR's 10-Y Financials

Financials (Next Earnings Date: 2017-02-24)


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q4 2015

HTWR Guru Trades in Q4 2015

Jim Simons 50,000 sh (New)
Steven Cohen Sold Out
» More
Q1 2016

HTWR Guru Trades in Q1 2016

Michael Price 30,000 sh (New)
Jim Simons 192,448 sh (+284.90%)
» More
Q2 2016

HTWR Guru Trades in Q2 2016

Chuck Royce 10,000 sh (New)
Mario Gabelli 58,550 sh (New)
Paul Tudor Jones 55,000 sh (New)
Michael Price Sold Out
Jim Simons 181,700 sh (-5.58%)
» More
Q3 2016

HTWR Guru Trades in Q3 2016

Paul Tudor Jones Sold Out
Chuck Royce Sold Out
Jim Simons Sold Out
Mario Gabelli Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with HTWR

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Devices » Medical Devices
Compare:NAS:SPNC, NAS:CYNO, NAS:VASC, NAS:MDXG, NYSE:ITGR, NAS:CSII, NAS:KTWO, NAS:CNMD, OTCPK:IOBCF, NAS:OFIX, NAS:INGN, NYSE:CRY, NAS:BABY, NAS:GNMK, OTCPK:MZRTF, NAS:ARAY, NAS:EXAC, NYSE:IVC, OTCPK:NMRD, OTCPK:IPDQF » details
Traded in other countries:HIN.Australia, HIY1.Germany,
Heartware International Inc is a medical device company. It develops and manufactures small implantable heart pumps, or ventricular assist devices, for the treatment of heart failure.

Heartware International Inc was incorporated in Delaware on July 29, 2008 and became the successor issuer to HeartWare Limited, an Australian corporation, on November 13, 2008, as a result of the Australian Court approved redomiciliation of HeartWare Limited from Australia to Delaware. HeartWare is a medical device company engaged in developing implantable blood pumps for the treatment of advanced heart failure. The Company operates one reportable segment which includes the design, manufacture and marketing of medical devices for the treatment of advanced heart failure. The HeartWare Ventricular Assist System, which includes a left ventricular assist device, or blood pump, patient accessories and surgical tools, is designed to provide circulatory support for patients with advanced heart failure. Beyond the HeartWare System, the company is also evaluating its next device, the Miniaturized Ventricular Assist Device. The MVAD is based on the same technology platform as the HeartWare System but adopts an axial flow, rather than a centrifugal flow, configuration and is being developed in multiple configurations. The MVAD designs are currently at the preclinical stage and undergoing animal studies focused on minimally invasive implantation techniques and are each approximately one-third the size of the HVAD Pump. The Company's competitors in the implantable cardiac assist space include Thoratec Corporation, Jarvik Heart, Inc., MicroMed Cardiovascular, Berlin Heart GmbH, and Sunshine Heart, Inc. HEARTWARE, HVAD, MVAD, PAL, CIRCULITE, SYNERGY and various company logos are the trademarks of the Company, in the United States, Europe, Australia and other countries.

Ratios

vs
industry
vs
history
P/B 6.01
HTWR's P/B is ranked lower than
75% of the 300 Companies
in the Global Medical Devices industry.

( Industry Median: 3.08 vs. HTWR: 6.01 )
Ranked among companies with meaningful P/B only.
HTWR' s P/B Range Over the Past 10 Years
Min: 2.64  Med: 7.24 Max: 20.14
Current: 6.01
2.64
20.14
P/S 3.92
HTWR's P/S is ranked lower than
61% of the 294 Companies
in the Global Medical Devices industry.

( Industry Median: 3.02 vs. HTWR: 3.92 )
Ranked among companies with meaningful P/S only.
HTWR' s P/S Range Over the Past 10 Years
Min: 1.75  Med: 10.66 Max: 132.21
Current: 3.92
1.75
132.21
Current Ratio 5.29
HTWR's Current Ratio is ranked higher than
81% of the 327 Companies
in the Global Medical Devices industry.

( Industry Median: 2.43 vs. HTWR: 5.29 )
Ranked among companies with meaningful Current Ratio only.
HTWR' s Current Ratio Range Over the Past 10 Years
Min: 1.23  Med: 7.54 Max: 23.06
Current: 5.29
1.23
23.06
Quick Ratio 4.54
HTWR's Quick Ratio is ranked higher than
79% of the 327 Companies
in the Global Medical Devices industry.

( Industry Median: 1.82 vs. HTWR: 4.54 )
Ranked among companies with meaningful Quick Ratio only.
HTWR' s Quick Ratio Range Over the Past 10 Years
Min: 1.23  Med: 6.56 Max: 21.57
Current: 4.54
1.23
21.57
Days Inventory 160.93
HTWR's Days Inventory is ranked lower than
61% of the 290 Companies
in the Global Medical Devices industry.

( Industry Median: 134.83 vs. HTWR: 160.93 )
Ranked among companies with meaningful Days Inventory only.
HTWR' s Days Inventory Range Over the Past 10 Years
Min: 160.93  Med: 188.6 Max: 8207.82
Current: 160.93
160.93
8207.82
Days Sales Outstanding 54.95
HTWR's Days Sales Outstanding is ranked higher than
68% of the 277 Companies
in the Global Medical Devices industry.

( Industry Median: 66.89 vs. HTWR: 54.95 )
Ranked among companies with meaningful Days Sales Outstanding only.
HTWR' s Days Sales Outstanding Range Over the Past 10 Years
Min: 46.9  Med: 74.48 Max: 268.25
Current: 54.95
46.9
268.25
Days Payable 55.00
HTWR's Days Payable is ranked lower than
52% of the 258 Companies
in the Global Medical Devices industry.

( Industry Median: 57.49 vs. HTWR: 55.00 )
Ranked among companies with meaningful Days Payable only.
HTWR' s Days Payable Range Over the Past 10 Years
Min: 52.74  Med: 71.8 Max: 3270.96
Current: 55
52.74
3270.96

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -6.10
HTWR's 3-Year Average Share Buyback Ratio is ranked lower than
57% of the 209 Companies
in the Global Medical Devices industry.

( Industry Median: -3.90 vs. HTWR: -6.10 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
HTWR' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -33.2  Med: -7.3 Max: -6.1
Current: -6.1
-33.2
-6.1

Valuation & Return

vs
industry
vs
history
Price/Net Current Asset Value 141.41
HTWR's Price/Net Current Asset Value is ranked lower than
98% of the 196 Companies
in the Global Medical Devices industry.

( Industry Median: 6.51 vs. HTWR: 141.41 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
HTWR' s Price/Net Current Asset Value Range Over the Past 10 Years
Min: 5  Med: 14.39 Max: 141.41
Current: 141.41
5
141.41
Price/Tangible Book 12.05
HTWR's Price/Tangible Book is ranked lower than
83% of the 266 Companies
in the Global Medical Devices industry.

( Industry Median: 4.06 vs. HTWR: 12.05 )
Ranked among companies with meaningful Price/Tangible Book only.
HTWR' s Price/Tangible Book Range Over the Past 10 Years
Min: 4.82  Med: 8.8 Max: 20.93
Current: 12.05
4.82
20.93
Price/Median PS Value 0.37
HTWR's Price/Median PS Value is ranked higher than
90% of the 231 Companies
in the Global Medical Devices industry.

( Industry Median: 1.02 vs. HTWR: 0.37 )
Ranked among companies with meaningful Price/Median PS Value only.
HTWR' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.19  Med: 0.98 Max: 11.26
Current: 0.37
0.19
11.26
Earnings Yield (Greenblatt) (%) -4.20
HTWR's Earnings Yield (Greenblatt) (%) is ranked lower than
62% of the 315 Companies
in the Global Medical Devices industry.

( Industry Median: 0.90 vs. HTWR: -4.20 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
HTWR' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: -14.55  Med: 0.7 Max: 0.7
Current: -4.2
-14.55
0.7

More Statistics

Revenue (TTM) (Mil) $257.0
EPS (TTM) $ -3.40
Short Percentage of Float5.11%
52-Week Range $25.02 - 87.38
Shares Outstanding (Mil)17.56

Analyst Estimate

Dec16 Dec17 Dec18
Revenue (Mil $) 240 260 307
EPS ($) -3.66 -2.97 -2.32
EPS w/o NRI ($) -3.66 -2.97 -2.32
EPS Growth Rate
(3Y to 5Y Estimate)
N/A
Dividends Per Share ($)
» More Articles for HTWR

Headlines

Articles On GuruFocus.com
Weekly Three-Year Low Highlights: Gap, NRG Energy, Buckle, HeartWare International Oct 13 2015 
Baron Funds Comments on HeartWare International May 05 2014 
Heartware International Inc (HTWR) CFO & COO David Mcintyre sells 2,857 Shares Feb 24 2011 
Heartware International Inc (HTWR) CFO & COO David Mcintyre sells 21,834 Shares Apr 30 2010 
Heartware International Inc (HTWR) CFO & COO David Mcintyre sells 5,271 Shares Mar 09 2010 
Heartware International Inc (HTWR) CFO & COO David Mcintyre sells 3,300 Shares Feb 26 2010 
Heartware International Inc (HTWR) CFO & COO David Mcintyre sells 4,967 Shares Jan 29 2010 
Heartware International Inc (HTWR) CFO & COO David Mcintyre sells 2,521 Shares Dec 07 2009 
Heartware International Inc (HTWR) CFO & COO David Mcintyre sells 1,580 Shares Dec 03 2009 
Heartware International Inc (HTWR) CFO & COO David Mcintyre sells 3,400 Shares Nov 30 2009 

More From Other Websites
Ranking the Activists for Proxy Season 2016 Dec 01 2016
Medtronic’s HeartWare Acquisition: The Must-Know Details Aug 31 2016
HEARTWARE INTERNATIONAL, INC. Files SEC form 8-K, Triggering Events That Accelerate or Increase a... Aug 26 2016
Medtronic's HeartWare Takeover Complete for $1.1 Billion Aug 24 2016
HEARTWARE INTERNATIONAL, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement,... Aug 23 2016
ETF’s with exposure to HeartWare International, Inc. : August 22, 2016 Aug 22 2016
HeartWare International, Inc. :HTWR-US: Earnings Analysis: Q2, 2016 By the Numbers : August 9, 2016 Aug 09 2016
HEARTWARE INTERNATIONAL, INC. Financials Aug 05 2016
HeartWare reports 2Q loss Jul 28 2016
HeartWare reports 2Q loss Jul 28 2016
HEARTWARE INTERNATIONAL, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Jul 28 2016
HeartWare International Reports $68.7 Million In Second Quarter 2016 Revenue Jul 28 2016
HeartWare International Reports $68.7 Million In Second Quarter 2016 Revenue Jul 28 2016
Medtronic’s Heartware Acquisition: Portfolio Impact Jul 08 2016
HeartWare (HTWR) Stock Downgraded at Barclays Jun 29 2016
Why Is Medtronic Acquiring Heartware? Jun 29 2016
INVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of HeartWare... Jun 28 2016
Medtronic Global Holdings SCA -- Moody's: Medtronic's HeartWare Deal and Dividend Increase are... Jun 28 2016
HeartWare International, Inc. Acquisition May Not Be in the Best Interests of HTWR Shareholders Jun 28 2016
Company News for June 28, 2016 Jun 28 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)